SCHEMBL4397979

SCHEMBL4397979

Cc1cc(-c2nc3cnccc3c(=O)n2NCc2ccc(Cl)cc2)ccc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.44
IDO1 P14902 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 3/20 0.41
MAPT P10636 2/20 0.41
TRPA1 O75762 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40
GAA P10253 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
TLR8 Q9NR97 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4203061 0.89 MEN1 (0.49) BRD4IDO1ALDH1A1MEN1POLB
SCHEMBL4189636 0.89 BRD4 (0.44) BRD4IDO1ALDH1A1MEN1POLB
SCHEMBL4194094 0.85 MEN1 (0.46) BRD4IDO1ALDH1A1MEN1POLB
SCHEMBL4197705 0.83 IDO1 (0.44) BRD4IDO1ALDH1A1MEN1POLB
SCHEMBL4196329 0.80 NPSR1 (0.47) BRD4IDO1ALDH1A1MEN1POLB
SCHEMBL4240250 0.77 KMT2A (0.62) ALDH1A1MEN1POLBKMT2ANPSR1
SCHEMBL4241303 0.77 ALDH1A1 (0.55) ALDH1A1MEN1POLBKMT2ANPSR1
SCHEMBL4193513 0.75 SMN1; SMN2 (0.50) BRD4ALDH1A1MEN1POLBKMT2A
SCHEMBL4238083 0.75 ALDH1A1 (0.56) ALDH1A1MEN1POLBKMT2ANPSR1
SCHEMBL4736516 0.75 POLB (0.65) ALDH1A1MEN1POLBKMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105124-A1 HETEROCYCLIC MODULATORS OF TGR5 KALYPSYS, INC. (US) 2009-04-23 US disclosed
US-20090105124-A1 HETEROCYCLIC MODULATORS OF TGR5 KALYPSYS, INC. (US) 2009-04-23 US disclosed
US-20090105124-A1 HETEROCYCLIC MODULATORS OF TGR5 KALYPSYS, INC. (US) 2009-04-23 US disclosed
WO-2009026241-A1 HETEROCYCLIC MODULATORS OF TGR5 KALYPSYS, INC. (US) 2009-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105124-A1 HETEROCYCLIC MODULATORS OF TGR5 GPBAR1, GPR119, GRK5 BRD4 2047/4885IDO1 3233/4885ALDH1A1 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.